Breast carcinoma
9 views | +0 today
Follow
Your new post is loading...
Your new post is loading...
Scooped by oncdoc7
Scoop.it!

2013 Top Stories in Oncology: Lung Cancer Research

2013 Top Stories in Oncology: Lung Cancer Research | Breast carcinoma | Scoop.it
2013 Top Stories in Oncology: Lung Cancer Research
oncdoc7's insight:

Jean Yves Douillard, MD

more...
No comment yet.
Scooped by oncdoc7
Scoop.it!

2013 Top Stories in Oncology: Breast Cancer

2013 Top Stories in Oncology: Breast Cancer | Breast carcinoma | Scoop.it
2013 Top Stories in Oncology: Breast Cancer
oncdoc7's insight:

Neoadjuvant Perjetta use

more...
No comment yet.
Rescooped by oncdoc7 from Breast Cancer News
Scoop.it!

Larry Norton: From A to B in Breast Cancer

Larry Norton: From A to B in Breast Cancer | Breast carcinoma | Scoop.it

Kathy D. Miller, MD: Hello. I am Kathy Miller, Associate Professor of Medicine at Indiana University School of Medicine in Indianapolis. Welcome to Medscape Oncology, Insights on Breast Cancer, coming to you from the 2013 Annual Meeting of the American Society of Clinical Oncology (ASCO®). Today I am honored to be joined by Dr. Larry Norton, Professor at the Weill Cornell Medical College and Deputy Physician-in-Chief of Breast Cancer Programs at the Memorial Sloan-Kettering Cancer Center in New York.

She interviews Larry Norton about:

Axillary Lymph Node InvolvementThe Yin and Yang of Adjuvant TreatmentClearing Up Confusion About Dose-Dense TreatmentBOLERO-3: Lessons in Walking Through Water


Via Susan Zager
more...
Susan Zager's curator insight, June 10, 2013 3:26 PM

You will need to register (for free) to see this article. It's a great look at topics covered at ASCO 2013 in relationship to breast cancer and hear Karen interview Larry Norton about the trials covered.

Scooped by oncdoc7
Scoop.it!

Weekly adjuvant paclitaxel for breast cancer has less toxicity : Oncology Practice

Weekly adjuvant paclitaxel for breast cancer has less toxicity : Oncology Practice | Breast carcinoma | Scoop.it
CHICAGO – Weekly paclitaxel is just as efficacious as dose-dense paclitaxel when it comes to adjuvant chemotherapy for breast cancer, but the weekly schedule has lower rates of certain important toxicities, according to data presented at the annual meeting of the American Society of Clinical Oncology.
The Southwest Oncology Group’s S0221 randomized trial tested combination chemotherapy regimens among 3,294 patients who had completed local therapy for early breast cancer.
Half of the patients rec
more...
No comment yet.
Scooped by oncdoc7
Scoop.it!

2013 Top Stories in Oncology: Colorectal Cancer Research

2013 Top Stories in Oncology: Colorectal Cancer Research | Breast carcinoma | Scoop.it
2013 Top Stories in Oncology: Colorectal Cancer Research
oncdoc7's insight:

Check KRAS mutations in exons 2, 3 and 4 AND NRAS exons 2 and 3.  Axel Grothey.  Dec 16, 2013

more...
No comment yet.
Scooped by oncdoc7
Scoop.it!

80032061: Sixth Current Concepts in the Multidisciplinary Management of Colorectal Cancer

80032061: Sixth Current Concepts in the Multidisciplinary Management of Colorectal Cancer | Breast carcinoma | Scoop.it
more...
No comment yet.